Lee Pharma
- All
- News
-
Hyderabad Pharma Firm Signs Agreement To Make Covid Drug 2-DG
Hyderabad-based Lee Pharma has entered into an agreement with the Indian Institute of Chemical Technology (IICT), a constituent laboratory of CSIR, to manufacture and commercialise 2-DG used to treat Covid patients, a statement said.
-
Two Indian Generics Makers End Battle to Copy Drugs Amid Patent Debate
Two Indian drug makers said they had given up a battle to copy drugs developed by Bristol Myers Squibb and AstraZeneca, blaming a lack of government support for cheap generics and pressure from Big Pharma.
-
Hyderabad Pharma Firm Signs Agreement To Make Covid Drug 2-DG
Hyderabad-based Lee Pharma has entered into an agreement with the Indian Institute of Chemical Technology (IICT), a constituent laboratory of CSIR, to manufacture and commercialise 2-DG used to treat Covid patients, a statement said.
-
Two Indian Generics Makers End Battle to Copy Drugs Amid Patent Debate
Two Indian drug makers said they had given up a battle to copy drugs developed by Bristol Myers Squibb and AstraZeneca, blaming a lack of government support for cheap generics and pressure from Big Pharma.
